Bilcare (NSE:BI) Cyclically Adjusted PS Ratio: (As of Aug. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:BI Bilcare Ltd NSE:BI
37 GF Score
Price ₹96.24
GF Value ₹61.81
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Bilcare Cyclically Adjusted PS Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PS Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bilcare  (NSE:BI) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Bilcare Cyclically Adjusted PS Ratio Related Terms


Bilcare Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Bilcare's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bilcare Cyclically Adjusted PS Ratio Chart

Bilcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.04 0.05 0.10 0.06

Bilcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.08 0.09 0.09 0.06

NSE:BI vs : Cyclically Adjusted PS Ratio Comparison

For the Packaging & Containers subindustry, Bilcare's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bilcare Cyclically Adjusted PS Ratio vs Packaging & Containers Industry

For the Packaging & Containers industry and Consumer Cyclical sector, Bilcare's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bilcare's Cyclically Adjusted PS Ratio falls into.


NSE:BI
37GF Score
Bilcare Ltd NSE:BI
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bilcare Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Bilcare's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, Bilcare's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=79.723/330.2130*330.2130
=79.723

Current CPI (Mar. 2026) = 330.2130.

Bilcare Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 283.013 241.018 387.749
201609 281.639 241.428 385.212
201612 269.006 241.432 367.927
201703 284.415 243.801 385.222
201706 279.948 244.955 377.386
201709 280.650 246.819 375.475
201712 299.754 246.524 401.513
201803 319.518 249.554 422.790
201806 317.315 251.989 415.818
201809 308.649 252.439 403.741
201812 308.332 251.233 405.262
201903 335.755 254.202 436.152
201906 297.622 256.143 383.687
201909 286.006 256.759 367.827
201912 141.207 256.974 181.452
202003 48.823 258.115 62.460
202006 58.951 257.797 75.511
202009 64.540 260.280 81.881
202012 66.505 260.474 84.311
202103 71.194 264.877 88.755
202106 75.488 271.696 91.746
202109 86.410 274.310 104.020
202112 88.183 278.802 104.444
202203 103.735 287.504 119.145
202206 105.336 296.311 117.388
202209 108.043 296.808 120.203
202212 104.470 296.797 116.232
202303 92.084 301.836 100.741
202306 77.514 305.109 83.892
202309 80.574 307.789 86.444
202312 74.316 306.746 80.001
202403 81.179 312.332 85.826
202406 82.336 314.175 86.539
202409 85.705 315.301 89.758
202412 84.282 315.605 88.183
202503 82.447 319.799 85.132
202506 79.441 322.561 81.326
202509 75.691 324.800 76.952
202512 77.098 324.054 78.563
202603 79.723 330.213 79.723

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Bilcare (NSE:BI) Overvalued in 2026?

Based on GuruFocus' analysis, Bilcare stock appears to be overvalued. The current stock price of ₹96.24 is trading 55.7% above its estimated GF Value™ of ₹61.81. GuruFocus considers Bilcare to be Significantly Overvalued.

Key valuation signals for NSE:BI:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: ₹61.81 vs. price of ₹96.24 (55.7% above fair value)
  • GF Score™: 37/100 with 7 warning signs

No single metric tells the full story. See the NSE:BI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bilcare Business Description

Comparable Companies
Other Exchanges 526853:India
Address 301 Kamal Kunj, 8 Shivaji Housing Society, Pune, MH, IND, 411016
Bilcare Ltd is an Indian company engaged in pharma packaging research solutions. It offers effective and affordable packaging solutions. It offers pharmaceutical packaging solutions comprising specialty polymer films and Aluminium foils used for packaging of solid dosage pharmaceutical products. It also provides Clinical Trial Materials (CTM) services to the pharmaceutical and biotechnology industries under Bilcare Global Clinical Supplies. It also offers packaging films solutions to ID Card industry, Specialty Films Applications, and Food packaging industry.
37GF Score

Get the complete analysis for NSE:BI

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹96.24
Price
₹61.81
GF Value